The Human antigen R (HuR) protein is an RNA-binding protein, ubiquitously expressed in human tissues, that orchestrates target RNA maturation and processing both in the nucleus and in the cytoplasm. A survey of known modulators of the RNA-HuR interactions is followed by a description of its structure and molecular mechanism of action – RRM domains, interactions with RNA, dimerization, binding modes with naturally occurring and synthetic HuR inhibitors. Then, the review focuses on HuR as a validated molecular target in oncology and briefly describes its role in inflammation. Namely, we show ample evidence for the involvement of HuR in the hallmarks and enabling characteristics of cancer, reporting findings from in vitro and in vivo studies; and we provide abundant experimental proofs of a beneficial role for the inhibition of HuR-mRNA interactions through silencing (CRISPR, siRNA) or pharmacological inhibition (small molecule HuR inhibitors).
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models / Assoni, Giulia; La Pietra, Valeria; Digilio, Rosangela; Ciani, Caterina.; Licata, Nausicaa Valentina; Micaelli, Mariachiara; Facen, Elisa; Tomaszewska, Weronika; Cerofolini, Linda; Perez-Rafols, Anna; Varela Rey, Marta; Fragai, Marco; Woodhoo, Ashwin; Marinelli, Luciana; Arosio, Daniela; Bonomo, Isabelle; Provenzani, Alessandro; Seneci, Pierfausto. - In: ADVANCED DRUG DELIVERY REVIEWS. - ISSN 0169-409X. - 181:(2022), pp. 11408801-11408827. [10.1016/j.addr.2021.114088]
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models
Assoni, Giulia;Digilio, Rosangela;Ciani, Caterina.;Licata, Nausicaa Valentina;Micaelli, Mariachiara;Facen, Elisa;Bonomo, Isabelle;Provenzani, Alessandro;Seneci, Pierfausto
2022-01-01
Abstract
The Human antigen R (HuR) protein is an RNA-binding protein, ubiquitously expressed in human tissues, that orchestrates target RNA maturation and processing both in the nucleus and in the cytoplasm. A survey of known modulators of the RNA-HuR interactions is followed by a description of its structure and molecular mechanism of action – RRM domains, interactions with RNA, dimerization, binding modes with naturally occurring and synthetic HuR inhibitors. Then, the review focuses on HuR as a validated molecular target in oncology and briefly describes its role in inflammation. Namely, we show ample evidence for the involvement of HuR in the hallmarks and enabling characteristics of cancer, reporting findings from in vitro and in vivo studies; and we provide abundant experimental proofs of a beneficial role for the inhibition of HuR-mRNA interactions through silencing (CRISPR, siRNA) or pharmacological inhibition (small molecule HuR inhibitors).File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0169409X21004816-main.pdf
Solo gestori archivio
Tipologia:
Versione editoriale (Publisher’s layout)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
3.83 MB
Formato
Adobe PDF
|
3.83 MB | Adobe PDF | Visualizza/Apri |
ADDR_FIN_modified 07-10.pdf
accesso aperto
Tipologia:
Post-print referato (Refereed author’s manuscript)
Licenza:
Creative commons
Dimensione
2.31 MB
Formato
Adobe PDF
|
2.31 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione